1235 studies found for:    multiple sclerosis.
Show Display Options
Rank Status Study
21 Recruiting Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases
Conditions: Neurodegenerative Diseases;   Amyotrophic Lateral Sclerosis;   Multiple Sclerosis;   Parkinson Disease
Intervention:
22 Completed Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Mycophenolate Mofetil (CellCept)
23 Completed
Has Results
12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: Rebif® New Formulation (RNF) using RebiSmartTM
24 Completed Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.
Condition: Multiple Sclerosis
Interventions: Drug: BIIB041 (PR Fampridine);   Other: Placebo
25 Recruiting Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Disease Modifying therapy
26 Completed Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Subjects With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis.
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: Daclizumab High Yield Process 150 mg;   Biological: Daclizumab High Yield Process 300 mg
27 Enrolling by invitation Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
28 Unknown  Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
29 Completed Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
30 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
31 Recruiting Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Ambulation Difficulty
Intervention: Other: Rhythmic Auditory Stimulation (RAS)
32 Not yet recruiting Implementing Physical Activity Guidelines for Adults With MS
Condition: Multiple Sclerosis
Intervention: Other: Direct Referral to physical activity
33 Completed
Has Results
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
Conditions: Multiple Sclerosis;   Neuropathic Pain
Interventions: Drug: Placebo;   Drug: Sativex
34 Unknown  Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Physical exercise training
35 Recruiting Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: PET with 11C-Flumazenil
36 Completed
Has Results
A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
37 Not yet recruiting MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Amiloride;   Drug: Riluzole;   Drug: Ibudilast;   Drug: Placebo
38 Active, not recruiting A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: AIN457
39 Completed
Has Results
A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis
Conditions: Detrusor Overactivity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
40 Completed Study Assessing the Interaction of Pantoprazole With Cladribine in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Cladribine;   Drug: Cladribine and Pantoprazole

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years